Antihypertensive agents and their use in treatment of hypertension

摘要

Riboflavin analogues, including both endo- and exocyclically substituted isoalloxazines which are competitive inhibitors of the enzyme flavokinase (EC 2.7.1.26) when administered in a non-toxic dosage, effectively reduce the blood pressure of a subject suffering from hypertension.